Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stock Market Highlights: BSE Sensex ends in green after 1,000 point intra-day crash; Nifty50 closes at 23,650 as IT stocks rally comes to rescue - The Times of India
Stock Market Highlights: BSE Sensex ends in green after 1,000 point intra-day crash; Nifty50 closes at 23,650 as IT stocks rally comes to rescueThe Times of IndiaWhy is market falling today? Sensex falls 600 points, Nifty below 23,500; 5 key factors behind bloodbathThe Economic TimesSensex Today Ends Marginally Higher | Nifty Above 23,600 | Gland Pharma Up 15%Equitymaster
Mangalam Worldwide’s board approves 1:10 stock split as smallcap rises 120% in a year
Mangalam Worldwide has approved a 1:10 stock split, under which each equity share with a face value of Rs 10 will be subdivided into 10 shares of Re 1 each, subject to shareholder and regulatory approvals. The decision was cleared by the board on May 15, 2026.
Alembic Pharma Q4 profit up 29% as US formulations business grows 11%; declares ₹12 dividend
The company also recommended a dividend of ₹12 per equity share of face value ₹2 each for shareholders. Shares of Alembic Pharmaceuticals Ltd ended at ₹782.10, down by ₹4.35, or 0.55%, on the BSE.
Nifty above 23,500 level; pharma shares in demand
At 10:30 IST, the barometer index, the S&P BSE Sensex, advanced 228.50 points or 0.31% to 74,837.48. The Nifty 50 index rose 98.85 points or 0.42% to 23,511.40.
Dr Reddy's Q4 results 2026: Profit plunges 86% YoY to ₹220 crore; board recommends a final dividend of ₹8
Dr Reddy's Q4 results 2026: Dr Reddy's Laboratories reported a sharp 86.2% YoY fall in its consolidated net profit to ₹220.1 crore for Q4FY26. The company's board recommended a final dividend of ₹8 per share of face value of ₹1 each for FY26.
Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26
An analysis of mutual fund portfolios revealed 29 stocks held exclusively by single schemes, with most underperforming in CY26. However, Satin Creditcare Network, Rossell Techsys, and Amanta Healthcare bucked the trend, delivering strong returns. Brooks Laboratories and EFC (I) were among those experiencing significant declines.
LTIMindtree Share Price Live Updates: LTIMindtree's beta value points to consistent performance
Cipla Share Price Live Updates: Cipla's beta value highlights consistent performance
Tata Motors PV Share Price Live Updates: Tata Motors PV showcases high beta value
L&T Share Price Live Updates: L&T's beta value points to increased volatility
Marico, Nestle, Laurus, Grasim and 15 others from Nifty 500 hit new highs
Vijaya Diagnostic Centre was quoting higher for the eight straight trading day, soaring 25 per cent during the period.
Biocon reports 63% YoY fall in Q4 profit, final dividend of Rs. 0.50 recommended
Biocon's fourth-quarter net profit saw a significant drop of 63 percent year-on-year. This decline was attributed to exceptional charges impacting the company's financials. However, core businesses demonstrated growth. The company successfully integrated its biosimilars and generics operations. This strategic move aims to enhance scale and market reach. Biocon is now focused on improving profitability and creating long-term value for shareholders.